| Abnova |
L002V3 |
C32 (human amelanotic melanoma) nuclear extract lysate (denatured) |
| Abnova |
L002V4 |
C32 (human amelanotic melanoma) nuclear extract lysate(non-denatured) |
| Abnova |
L003V3 |
JAR (human choriocarcinoma) nuclear extract lysate (denatured) |
| Abnova |
L003V4 |
JAR (human choriocarcinoma) nuclear extract lysate (non-denatured) |
| Abnova |
L004V3 |
LNCaP clone FGC (human prostate carinoma) nuclear extract lysate (denatured) |
| Abnova |
L004V4 |
LNCaP clone FGC (human prostate carcinoma) nuclear extract lysate (non-denatured) |
| Abnova |
L005V3 |
SW-13 (human small cell carcinoma of the adrenal cortex) nuclear extract lysate (denatured) |
| Abnova |
L005V4 |
SW-13 (human small cell carcinoma of the adrenal cortex) nuclear extract lysate (non-denatured) |
| Abnova |
L006V3 |
T-47D (human breast duct carinoma) nuclear extract lysate (denatured) |
| Abnova |
L006V4 |
T-47D (human breast duct carinoma) nuclear extract lysate (non-denatured) |
| Abnova |
L007V3 |
THP-1 (human acute monocytic leukemia) nuclear extract lysate (denatured) |
| Abnova |
L007V4 |
THP-1 (human acute monocytic leukemia) nuclear extract lysate (non-denatured) |
| Abnova |
L008V3 |
IMR-32 (human neuroblastoma) nuclear extract lysate (denatured) |
| Abnova |
L008V4 |
IMR-32 (human neuroblastoma) nuclear extract lysate (non-denatured) |
| Abnova |
L009V3 |
K-562 (human chronic myelogenous leukemia) nuclear extract lysate (denatured) |
| Abnova |
L009V4 |
K-562 (human chronic myelogenous leukemia) nuclear extract lysate (non-denatured) |
| Abnova |
L011V3 |
PLC/PRF/5 (human hepatoma) nuclear extract lysate (denatured) |
| Abnova |
L011V4 |
PLC/PRF/5 (human hepatoma) nuclear extract lysate (non-denatured) |
| Abnova |
L012V3 |
PC-12 (rat adrenal gland pheochromocytoma) nuclear extract lysate (denatured) |
| Abnova |
L012V4 |
PC-12 (rat adrenal gland pheochromocytoma) nuclear extract lysate (non-denatured) |
| Abnova |
L013V3 |
Hela S3 (human cervical epithlioid carcinoma) nuclear extract lysate (denatured) |
| Abnova |
L013V4 |
HeLa S3 (human cervical epithlioid carcinoma) nuclear extract lysate (non-denatured) |
| Abnova |
L014V3 |
HL-60 (human promyelocytic leukemia) nuclear cell lysate (denatured) |
| Abnova |
L014V4 |
HL-60 (human promyelocytic leukemia) nuclear cell lysate (non-denatured) |
| Abnova |
L015V3 |
A-431 (human epidermoid carcinoma) nuclear extract lysate (denatured) |
| Abnova |
L015V4 |
A-431 (human epidermoid carcinoma) nuclear extract lysate (non-denatured) |
| Abnova |
L018V3 |
NIH/3T3 (mouse NIH/Swiss embryo) nuclear extract lysate (denatured) |
| Abnova |
L018V4 |
NIH/3T3 (mouse NIH/Swiss embryo) nuclear extract lysate (non-denatured) |
| Abnova |
L019V3 |
HepG2/C3A (human hepatoblastoma) nuclear extract lysate (denatured) |
| Abnova |
L019V4 |
HepG2/C3A (human hepatoblastoma) nuclear extract lysate (non-denatured) |
| Abnova |
L020V3 |
COLO 320 HSR (human adenocarcinoma) nuclear extract lysate (denatured) |
| Abnova |
L020V4 |
COLO 320 HSR (human adenocarcinoma) nuclear extract lysate (non-denatured) |
| Abnova |
L021V3 |
MES-SA/Dx5 (human uterine sarcoma, MDR variant) nuclear extract lysate (denatured) |
| Abnova |
L021V4 |
MES-SA/Dx5 (human uterine sarcoma, MDR variant) nuclear extract lysate (non-denatured) |
| Abnova |
L022V3 |
U-2 OS (human osterogenic sarcoma) nuclear extract lysate (denatured) |
| Abnova |
L022V4 |
U-2 OS (human osterogenic sarcoma) nuclear extract lysate (non-denatured) |
| Abnova |
L024V3 |
Raw 264.7 (mouse macrophage, Abelson murine leukemia virus transformed) nuclear extract lysate (denatured) |
| Abnova |
L024V4 |
Raw 264.7 (mouse macrophage, Abelson murine leukemia virus transformed) nuclear extract lysate (non-denatured) |
| Abnova |
L025V3 |
A-549 (human lung carcinoma) nuclear extract lysate (denatured) |
| Abnova |
L025V4 |
A-549 (human lung carcinoma) nuclear extract lysate (non-denatured) |
| Abnova |
L028V3 |
SJCRH30 (human habdomyosarcoma) nuclear extract lysate (denatured) |
| Abnova |
L028V4 |
SJCRH30 (human rhabdomyosarcoma) nuclear extract lysate (non-denatured) |
| Abnova |
L042V3 |
Y-79 (human retinoblastoma) nuclear extract lysate (denatured) |
| Abnova |
L042V4 |
Y-79 (human retinoblastoma) nuclear extract lysate (non-denatured) |
| Abnova |
L046V3 |
MCF-7 (human breast adenocarcinoma) nuclear extract lysate (denatured) |
| Abnova |
L046V4 |
MCF-7 (human breast adenocarcinoma) nuclear extract lysate (non-denatured) |
| Abnova |
L048V3 |
SKOV-3 (human adenocarcinoma) nuclear extract lysate (denatured) |
| Abnova |
L048V4 |
SKOV-3 (human adenocarcinoma) nuclear extract lysate (non-denatured) |
| Abnova |
L049V3 |
LS1034 (human cecal carcinoma) nuclear extract lysates (denatured) |
| Abnova |
L049V4 |
LS1034 (human cecal carcinoma) nuclear extract lysates (non-denatured) |
| Abnova |
L050V3 |
SK-BR-3 (human breast adenocarcinoma) nuclear extract lysate (denatured) |
| Abnova |
L050V4 |
SK-BR-3 (human breast adenocarcinoma) nuclear extract lysate (non-denatured) |
